Study guide
2.1 Skin Anatomy, Epidermal Biology & Barrier Function
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
2.1 Skin Anatomy, Epidermal Biology & Barrier Function
Key Takeaways Explain This Topic AI
Epidermal renewal relies on an orchestrated 28-day transit cycle where basal stem cells express Keratins 5 and 14, switching during suprabasal commitment to Keratins 1 and 10; mutations in these gene pairs cause Epidermolysis Bullosa Simplex and Epidermolytic Ichthyosis, respectively.
The cornified cell envelope (CE) is an insoluble 15-nm protein sheath assembled beneath the plasma membrane through calcium-dependent transglutaminase cross-linking (TGase-1, 3, and 5) of loricrin (70-85% of protein mass), involucrin, envoplakin, and small proline-rich proteins.
The extracellular permeability barrier consists of lipid lamellar sheets comprising ceramides, cholesterol, and free fatty acids in an approximately 50:25:15 ratio by weight (roughly equimolar), extruded via exocytosis of lamellar bodies (Odland bodies) at the stratum granulosum-corneum junction.
The dermo-epidermal junction (DEJ) comprises four ultrastructural tiers—hemidesmosomes, lamina lucida, lamina densa, and sub-lamina densa—anchored by BP180/BP230, laminin 332, type IV collagen, and type VII collagen anchoring fibrils, which serve as targeted autoantigens in pemphigoid/EBA and mutation targets in inherited epidermolysis bullosa.
Cutaneous wound repair progresses through four overlapping phases: haemostasis (minutes), inflammation (neutrophils transitioning to M2 macrophages over 1-3 days), proliferation (re-epithelialisation via MMP-1 and granulation tissue formation), and remodelling, where type III collagen is replaced by type I collagen to reach a maximal plateau of 70-80% pre-injury tensile strength.
Last updated: September 2026
2.1 Skin Anatomy, Epidermal Biology & Barrier Function
Section focus: Epidermal differentiation kinetics, junctional complex ultrastructure, basement membrane autoantigen mapping, and the biochemistry of the epidermal barrier. These molecular targets explain the genodermatoses and autoimmune bullous diseases taught later in this guide.
1. Epidermal Architecture and Stratification
The human epidermis is a continuously renewing, stratified squamous keratinising epithelium composed predominantly (~90–95%) of keratinocytes , interspersed with dendritic and neuroendocrine populations: melanocytes , Langerhans cells , and Merkel cells . The epidermis maintains architectural homeostasis through a strictly regulated differentiation program extending from the proliferative basal layer to the anucleate, cornified squames of the surface.
Transit Kinetics and Cellular Turnover
Under physiological steady-state conditions, basal keratinocytes undergo asymmetrical division, yielding one stem cell and one transit-amplifying cell. The transit-amplifying daughter cell detaches from the basement membrane zone and ascends through the suprabasal strata:
Basal-to-granular transit: Approximately 14 days .
Stratum corneum transit (desquamation): Approximately 14 days .
Total epidermal renewal time: 28 to 30 days .
In hyperproliferative dermatoses such as psoriasis vulgaris , this transit cycle is dramatically accelerated to 3 to 5 days , leading to incomplete terminal differentiation, failure of nuclear degradation ( parakeratosis ), and defective lipid barrier formation.
The Stratified Epidermal Layers
Stratum Basale (Germinativum): A single layer of mitotically active, columnar-to-cuboidal cells resting upon the basement membrane zone. Keratinocytes are tethered to the basal lamina via hemidesmosomes and to neighbouring basal cells via desmosomes . Basal cells express the primary keratin intermediate filament pair Keratin 5 (K5) and Keratin 14 (K14) . This layer harbours epidermal stem cells within specialised interfollicular niches and rete ridges.
Stratum Spinosum (Prickle Cell Layer): Composed of 5 to 10 layers of polygonal cells. Under light microscopy, post-fixation shrinkage artefact highlights abundant intercellular desmosomal bridges, imparting a "prickled" appearance. As keratinocytes commit to differentiation, transcription shifts from K5/K14 to the suprabasal pair Keratin 1 (K1) and Keratin 10 (K10) . Early synthesis of the protein precursors of the cornified envelope (involucrin) begins here.
Stratum Granulosum (Granular Layer): Consists of 1 to 3 layers of flattened keratinocytes containing intensely basophilic keratohyalin granules . These non-membrane-bound granules store high-molecular-weight profilaggrin , loricrin , and keratin-aggregating proteins. Concurrently, membrane-bound lamellar bodies ( Odland bodies , or keratinosomes , ~0.1–0.3 µm) emerge, packed with polar lipids (glucosylceramides, sphingomyelin, cholesterol) and hydrolytic processing enzymes.
Stratum Lucidum: A thin, clear, highly refractile eosinophilic transition band present strictly in thick, glabrous skin ( palmoplantar epidermis ). Keratinocytes have lost their nuclei and organelles, and keratohyalin granules have dissolved into an amorphous intermediate substance termed eleidin .
Stratum Corneum (Horny Layer): The final physiological product of epidermal differentiation, comprising 15 to 25 layers (expanding to >100 layers on plantar surfaces) of flattened, hexagonal, anucleate corneocytes . Corneocytes are embedded within an extracellular lipid matrix, establishing the quintessential "bricks and mortar" permeability barrier.
Non-Keratinocyte Epidermal Inhabitants
Cell Type Embryological Origin Histological Location Diagnostic Markers Primary Biological Function
Melanocyte Neural crest Stratum basale (1 melanocyte per 10 basal keratinocytes) S100, Melan-A (MART-1), HMB-45, SOX10, Tyrosinase Synthesis of eumelanin and pheomelanin in stage I–IV melanosomes; transfer via dendritic tips to ~36 neighbouring keratinocytes ( epidermal melanin unit ) for supranuclear UV shielding.
Langerhans Cell Bone marrow (fetal liver/haematopoietic stem cell) Mid-stratum spinosum (2–4% of epidermal cells) CD1a, Langerin (CD207), S100, HLA-DR; electron microscopy reveals Birbeck granules Professional antigen-presenting cell (APC); captures microbial antigens, downregulates E-cadherin, upregulates CCR7, and migrates to regional lymph nodes.
Merkel Cell Neural crest / epidermal stem cell lineage Stratum basale (abundant in fingertips, lips, hair follicle outer root sheath) Cytokeratin 20 (CK20, characteristic perinuclear dot pattern), Chromogranin A, Synaptophysin Mechanoreceptor mediating light touch and pressure perception (slowly adapting type I mechanoreceptor); origin cell for neuroendocrine Merkel cell carcinoma .
2. Keratinocyte Differentiation & Intermediate Filament Biology
Keratins represent the primary structural cytoskeletal intermediate filaments of epithelial cells. They assemble as obligate heteropolymers , pairing one Type I acidic keratin (K9–K28; gene cluster on chromosome 17q21) with one Type II basic/neutral keratin (K1–K8, K71–K86; gene cluster on chromosome 12q13) in a strict 1:1 molar stoichiometry.
Keratin Expression Profiles and Associated Genodermatoses
Basal Keratins (K5 / K14): Form the flexible mechanical framework of basal keratinocytes. Point mutations disrupting the alpha-helical rod domains (e.g., L10 helix initiation or termination motifs) prevent stable filament bundling, resulting in basal cell cytolysis upon shear stress.
Clinical Entity: Epidermolysis Bullosa Simplex (EBS) (Dowling-Meara, Köbner, and Weber-Cockayne phenotypes; autosomal dominant, rarely recessive).
Suprabasal Keratins (K1 / K10): Aggregate into thick, dense tonofilament bundles that stiffen spinous and granular keratinocytes against compressive trauma.
Clinical Entity: Epidermolytic Ichthyosis (EI) (formerly bullous congenital ichthyosiform erythroderma; KRT1 or KRT10 mutations; features suprabasal blistering and erythroderma in infancy, evolving into generalized hystrix-like hyperkeratosis). Note: KRT1 mutations also present with severe palmoplantar keratoderma, whereas KRT10 mutations spare the palms and soles because Keratin 9 (K9) compensates on palmoplantar surfaces.
Palmoplantar Keratin (K9): Exclusively expressed in suprabasal palmoplantar epidermis.
Clinical Entity: Epidermolytic Palmoplantar Keratoderma (Vörner type) ( KRT9 mutations).
Mucosal Keratins (K4 / K13): Expressed in suprabasal stratified squamous non-keratinising mucosa.
Clinical Entity: White Sponge Naevus (asymptomatic, thickened white spongy plaques on the oral mucosa; KRT4 or KRT13 mutations).
Corneal Keratins (K3 / K12): Mutations cause Meesmann corneal dystrophy .
Nail and Hair Follicle Keratins (K6a, K6b, K16, K17): Mutations cause Pachyonychia Congenita types 1 and 2, characterized by painful plantar keratoderma, hypertrophic nail dystrophy, and follicular hyperkeratosis.
Profilaggrin Processing and Natural Moisturising Factor (NMF)
In the upper stratum spinosum and stratum granulosum, keratinocytes transcribe profilaggrin , a massive (>400 kDa), insoluble, heavily phosphorylated polyprotein consisting of 10 to 12 tandem filaggrin repeats flanking N- and C-terminal domains. Profilaggrin is sequestered within keratohyalin granules.
During terminal cornification, profilaggrin undergoes rapid dephosphorylation and proteolytic cleavage orchestrated by calpain-1 , matriptase (membrane-bound serine protease), and SASPase (skin aspartic protease). This cascade liberates monomeric filaggrin (filament-aggregating protein) (~37 kDa).
Tonofilament Aggregation: Filaggrin monomers bind to K1/K10 intermediate filaments, condensing them into parallel tonofilament bundles. This causes collapse of the keratinocyte cytoplasm and flattening into disc-like squames.
Proteolytic Degradation to NMF: As corneocytes transit through the mid-stratum corneum, filaggrin is processed by caspase-14 , bleomycin hydrolase , and calpain-1 into free amino acids:
Histidine: Enzymatically converted by histidase into trans-urocanic acid (trans-UCA) , an endogenous chromophore providing physiological photoprotection against UVB radiation, which photoisomerizes to immunosuppressive cis-UCA.
Glutamine: Converted into pyrrolidone-5-carboxylic acid (PCA) , an intensely hygroscopic humectant.
Arginine: Cleaved into urea, citrulline, and ornithine.
Together, these low-molecular-weight hygroscopic compounds constitute the Natural Moisturising Factor (NMF) , maintaining stratum corneum hydration, flexibility, and facilitating desquamatory enzyme activity.
Exam Trap: Loss-of-function nonsense mutations in the filaggrin gene ( FLG , chromosome 1q21 in the Epidermal Differentiation Complex, notably R501X and 2282del4 in European cohorts) cause semi-dominant Ichthyosis Vulgaris (fine fish-like scaling, hyperlinear palms/soles, keratosis pilaris) and represent the strongest known monogenic predisposing risk factor for Atopic Dermatitis , defective barrier permeability, and cutaneous sensitisation ( allergic march ).
- 3. The Epidermal Permeability Barrier
- The Cornified Cell Envelope (CE)
The cornified cell envelope (CE) is an exceptionally tough, insoluble, 15-nm thick protein shell assembled beneath the inner surface of the plasma membrane during terminal keratinocyte apoptosis. It replaces the fragile lipid bilayer of the living keratinocyte.
Assembly is driven by calcium-activated transglutaminases (TGases) , which catalyze stable covalent N-epsilon-(gamma-glutamyl)lysine isopeptide bonds between lysine and glutamine residues:
Loricrin: Accounts for 70% to 85% of total CE protein mass. It is a glycine-serine-cysteine-rich protein providing elasticity and mechanical resistance. Mutations in loricrin cause Vohwinkel syndrome variant with ichthyosis (mutilating keratoderma with pseudo-ainhum and ichthyosiform dermatosis, sparing hearing).
Involucrin: Synthesized early in the spinous layer; acts as the primary scaffold protein deposited against the inner plasma membrane.
Small Proline-Rich Proteins (SPRRs) and Envoplakin / Periplakin: Act as cross-linking adapters anchoring the scaffold to desmosomal plaques.
Transglutaminase Isoforms:
TGase-1 ( TGM1 ): Membrane-bound transglutaminase. Autosomal recessive mutations in TGM1 cause classic Lamellar Ichthyosis (large, dark, plate-like scales, collodion membrane at birth, severe ectropion).
TGase-3 ( TGM3 ): Soluble epidermal and follicular enzyme; serves as the autoantigen targeted by IgA antibodies in Dermatitis Herpetiformis .
TGase-5 ( TGM5 ): Essential for superficial subcorneal cross-linking; mutations cause Acral Peeling Skin Syndrome (painless, superficial blistering of palms and soles).
The Corneocyte Lipid Envelope (CLE) and Intercellular Lipid Mortar
The extracellular hydrophobic matrix separating corneocytes is synthesized and released by lamellar bodies (Odland bodies) , which fuse with the apical plasma membrane of granular keratinocytes, extruding their lamellar contents into the extracellular space. +-------------------------------------------------------------------------+
- | STRATUM CORNEUM ARCHITECTURE |
- | |
- | +-----------------------------------------------------------------+ |
- | | CORNEOCYTE ("THE BRICK") | |
- | | - Anucleated, flattened proteinaceous interior | |
- | | - Condensed Keratin 1/10 filaments bundled by Filaggrin | |
- | | - Cornified Cell Envelope (Loricrin, Involucrin, TGase-1) | |
- | +-----------------------------------------------------------------+ |
- | | | |
- | +====== Corneocyte Lipid Envelope (CLE: omega-hydroxyceramides) ===+
- | |
- | ~~~~~~~~~~~~~~~~ INTERCELLULAR LIPID MATRIX ("THE MORTAR") ~~~~~~~~~~ |
- | - Ceramides (50%): Sphingoid base + fatty acid (Ceramide 1 EOS) |
- | - Cholesterol (25%): Regulates fluidity and phase behaviour |
- | - Free Fatty Acids (15%): Saturated long-chain (palmitic, stearic) |
- | - Organised into repeating Lamellar Gel Phases (LPP 13 nm / SPP 6 nm) |
- +-------------------------------------------------------------------------+
Composition: The lipid mortar contains the three lipid classes in a roughly equimolar ratio (approximately 50:25:15 by weight):
Ceramides (~50% by weight): Particularly Ceramide 1 (EOS), which features an esterified omega-hydroxy fatty acid with linoleic acid that links adjacent lipid bilayers.
Cholesterol (~25%): Modulates membrane fluidity.
Free Fatty Acids (~15%): Predominantly long-chain saturated fatty acids (e.g., palmitic, stearic, behenic acids).
The Corneocyte Lipid Envelope (CLE): A monomolecular layer of omega-hydroxyceramides covalently esterified directly onto glutamate residues of involucrin and envoplakin on the outer face of the CE by TGase-1. The CLE acts as a critical hydrophobic interface, anchoring the extracellular lipid lamellae to the proteinaceous corneocyte.
Acid Mantle: The stratum corneum maintains an acidic surface pH ( 4.5 to 5.5 ), sustained by the sodium-hydrogen antiporter 1 ( NHE1 ), secretory phospholipase A2 ( sPLA2 ), and filaggrin degradation products. This acid mantle inhibits pathogenic bacterial colonization ( Staphylococcus aureus ), optimizes lipid-processing enzyme activity ( beta-glucocerebrosidase and acid sphingomyelinase ), and prevents premature desquamation by regulating kallikrein serine proteases ( KLK5 , KLK7 ).
4. Intercellular Junctions: Desmosomes, Adherens, and Gap Junctions
Epidermal cohesion and paracrine cell-cell communication rely on specialised junctional complexes:
Desmosomes (Maculae Adherentes)
Desmosomes provide high-strength mechanical coupling by linking the keratin intermediate filament cytoskeleton of adjacent cells. Ultrastructurally, they consist of:
Transmembrane Cadherins (Calcium-Dependent):
Desmogleins (DSG1 to DSG4): DSG1 is expressed superficially (maximal in the stratum granulosum and spinosum; low in basal layers; only low-level expression in mucous membranes). DSG3 is expressed predominantly in the basal and parabasal layers of the epidermis and throughout the full thickness of stratified squamous mucous membranes.
Desmocollins (DSC1 to DSC3): DSC1 mirrors DSG1 distribution (superficial), while DSC3 mirrors DSG3 (basal).
Armadillo Protein Plaque: Plakoglobin (gamma-catenin) and Plakophilins (PKP1 to PKP3) bind directly to the cytoplasmic tails of desmogleins and desmocollins.
Plakin Family Cytolinkers: Desmoplakin (DSP) forms an obligate bridge linking plakoglobin and plakophilins directly to keratin tonofilaments.
Clinical and Pathological Correlates of the Desmosome
Pemphigus Foliaceus: IgG autoantibodies target Desmoglein 1 (DSG1) . Blistering occurs high in the epidermis (subcorneal acantholysis). Mucous membranes are clinically spared because mucosal epithelium expresses abundant DSG3, which compensates for the loss of DSG1.
Pemphigus Vulgaris (Mucosal-Dominant): IgG autoantibodies target Desmoglein 3 (DSG3) . Causes suprabasal acantholysis in mucous membranes. Skin is spared because epidermal DSG1 compensates for DSG3 inhibition.
Pemphigus Vulgaris (Mucocutaneous): IgG autoantibodies target both DSG3 and DSG1 , causing widespread flaccid cutaneous bullae and severe mucosal ulceration.
Staphylococcal Scalded Skin Syndrome (SSSS) & Bullous Impetigo: Staphylococcus aureus (phage group 2, types 71 and 55) secretes Exfoliative Toxin A and B (ETA/ETB) , which act as site-specific glutamate serine proteases that cleave the extracellular domain of DSG1 between domains EC3 and EC4 , causing painless, sterile, subcorneal shearing without mucosal involvement.
Naxos Disease: Autosomal recessive mutation in Plakoglobin ( JUP ) ; triad of arrhythmogenic right ventricular cardiomyopathy (ARVC), woolly hair, and diffuse palmoplantar keratoderma.
Carvajal Syndrome: Autosomal recessive mutation in Desmoplakin ( DSP ) ; triad of dilated left ventricular cardiomyopathy, woolly hair, and striate palmoplantar keratoderma.
Adherens, Tight, and Gap Junctions
Adherens Junctions (Zonulae Adherentes): Positioned immediately below tight junctions; mediated by transmembrane E-cadherin and P-cadherin , linked to the actin cytoskeleton via alpha-catenin and beta-catenin . Vital for cellular polarity and contact inhibition of growth.
Tight Junctions (Zonulae Occludentes): Localized to the stratum granulosum; formed by claudins (claudin-1, claudin-4), occludin , and zonula occludens proteins (ZO-1, ZO-2) . Creates a selective paracellular seal that regulates ion and water flux. Claudin-1 mutations cause NISCH syndrome (neonatal ichthyosis-sclerosing cholangitis).
Gap Junctions: Hexameric assemblies of transmembrane connexins forming aqueous hemichannels ( connexons ) that allow direct intercellular exchange of ions and secondary messengers (cAMP, Ca²⁺, IP3):
Connexin 26 (Cx26 / GJB2): Mutations cause Vohwinkel syndrome (classic sensorineural deafness with honeycombed keratoderma and starfish-shaped pseudo-ainhum), KID syndrome (keratitis-ichthyosis-deafness), and non-syndromic sensorineural hearing loss.
Connexin 30 (Cx30 / GJB6): Mutations cause Clouston hidrotic ectodermal dysplasia (palmoplantar keratoderma, dystrophic nails, severe alopecia, normal dentition/sweating).
Connexin 31 (Cx31 / GJB3): Mutations cause Erythrokeratodermia Variabilis (EKV) .
5. Dermo-Epidermal Junction (DEJ) Ultrastructure
The dermo-epidermal junction (basement membrane zone, BMZ) is a specialized mechanical structure adhering the avascular epidermis to the vascularized dermis. Ultrastructurally, transmission electron microscopy delineates four micro-anatomical zones : +=========================================================================+
- | DERMO-EPIDERMAL JUNCTION (DEJ) ULTRASTRUCTURE |
- +=========================================================================+
- | 1. HEMIDESMOSOMAL ZONE (Intracellular & Transmembrane Plaque) |
- | - Plectin (HD1) & BP230 (BPAG1-e): Intracellular inner plaque |
- | - BP180 (Type XVII Collagen / BPAG2): Transmembrane, NC16A domain |
- | - Integrin alpha6beta4 (α6β4): Transmembrane cytolinker |
- +-------------------------------------------------------------------------+
- | 2. LAMINA LUCIDA (Electron-lucent, 20-40 nm width) |
- | - Anchoring Filaments: Laminin 332 (α3β3γ2 chains, formerly Lam-5) |
- | - Extracellular rod domains of BP180 & α6β4 integrin |
- +-------------------------------------------------------------------------+
- | 3. LAMINA DENSA (Electron-dense, 30-60 nm width) |
- | - Type IV Collagen: Triple-helical planar meshwork |
- | - Perlecan (Heparan sulfate proteoglycan) & Nidogen-1 (Entactin) |
- +-------------------------------------------------------------------------+
- | 4. SUB-LAMINA DENSA ZONE (Fibroreticular Lamina) |
- | - Anchoring Fibrils: Type VII Collagen (COL7A1 antiparallel dimers) |
- | - Anchoring Microfibrils: Fibrillin-1 |
- | - Interstitial Dermal Collagen Fibres: Types I and III Collagen |
- +=========================================================================+
- Molecular Components, Autoimmune Targets, and Genodermatoses
Anatomical Zone Molecular Component Target in Autoimmune Bullous Disease Associated Inherited Disease (Genodermatosis)
Hemidesmosome (Inner Plaque) Plectin Paraneoplastic Pemphigus (minor target) EBS with Muscular Dystrophy ( PLEC mutations)
Hemidesmosome (Inner Plaque) BP230 (BPAG1-e) Bullous Pemphigoid (intracellular target) Autosomal recessive EBS ( DST mutations)
Hemidesmosome (Transmembrane) BP180 (Type XVII Collagen / BPAG2) Bullous Pemphigoid (pathogenic NC16A domain), Pemphigoid Gestationis , Linear IgA Disease , Cicatricial Pemphigoid Junctional EB (non-Herlitz / JEB intermediate) ( COL17A1 mutations)
Hemidesmosome (Transmembrane) Integrin alpha6beta4 Ocular Mucous Membrane Pemphigoid (anti-beta4 subunit) Junctional EB with Pyloric Atresia ( ITGA6 , ITGB4 mutations)
Lamina Lucida Laminin 332 (Laminin 5) Anti-Laminin 332 Mucous Membrane Pemphigoid (strong malignancy association: adenocarcinoma) Herlitz Junctional EB (JEB severe) ( LAMA3 , LAMB3 , LAMC2 mutations; early neonatal lethality)
Lamina Densa Type IV Collagen Goodpasture syndrome (alpha-3 chain in renal/pulmonary BMZ) Alport syndrome (hereditary nephritis with sensorineural deafness)
Lamina Densa Nidogen / Entactin Secondary target in select atypical immunobullous eruptions Essential bridge linking Laminin 332 to Type IV Collagen
Sub-Lamina Densa Type VII Collagen (Anchoring Fibrils) Epidermolysis Bullosa Acquisita (EBA) , Bullous Systemic Lupus Erythematosus (BSLE) Dystrophic Epidermolysis Bullosa (DEB) ( COL7A1 mutations; dominant and severe recessive / Hallopeau-Siemens DEB)
- 6. Dermal Architecture, Appendages & Cutaneous Wound Healing
- The Dermis and Extracellular Matrix
The dermis is divided into two distinct anatomical compartments:
Papillary Dermis: The thin, superficial zone directly interdigitating with epidermal rete ridges. Composed of loose connective tissue, thin Type III collagen fibers, branching oxytalan and elaunin elastic fibers, and capillary loops providing nutritive support to the avascular epidermis.
Reticular Dermis: The thick, deep zone extending to the subcutaneous fat. Characterized by dense, coarse bundles of Type I collagen (constituting 80–85% of total dermal collagen, paired with 15% Type III collagen), mature elastin fibers, and ground substance rich in glycosaminoglycans ( hyaluronic acid , dermatan sulphate ).
Cutaneous Appendages
Pilosebaceous Unit: Consists of the hair follicle, sebaceous gland, and arrector pili muscle. Follicular stem cells reside within the bulge region (CD34+, Keratin 15+), capable of regenerating the hair follicle and re-epithelialising deep cutaneous wounds. Hair growth cycles through Anagen (active growth; 2–7 years; ~85–90% of scalp follicles), Catagen (apoptosis-driven involution; 2–3 weeks; ~1%), and Telogen (resting phase; 2–3 months; ~10–15%), followed by Exogen (active shedding).
Sebaceous Glands: Holocrine glands responsive to androgens; secrete sebum composed of triglycerides, wax esters, squalene, and free fatty acids.
Eccrine Sweat Glands: Merocrine tubular glands distributed across the entire skin surface (highest density on palms, soles, and forehead); innervated by postganglionic sympathetic cholinergic fibers; essential for thermoregulation.
Apocrine Sweat Glands: Decapitation-mode secretion glands located primarily in the axillae, anogenital region, and areolae; inactive until puberty; responsive to adrenergic stimuli; produce odorless secretion that develops axillary odor upon bacterial cleavage.
Phases of Cutaneous Wound Healing
Following tissue injury, cutaneous architecture is restored through four sequential, overlapping phases: +=============================================================================+
- | PHASES OF CUTANEOUS WOUND REPAIR |
- +=============================================================================+
- | 1. HAEMOSTASIS (Immediate / Minutes) |
- | - Vascular vasoconstriction -> Platelet aggregation |
- | - Extrinsic/intrinsic coagulation -> Fibrin-fibronectin provisional plug |
- | - Platelet degranulation releases PDGF, TGF-beta, EGF, FGF |
- +-----------------------------------------------------------------------------+
- | 2. INFLAMMATION (Hours to Days 1-4) |
- | - Neutrophils infiltrate (first 24-48 h): NETs, phagocytosis |
- | - Monocytes recruited -> Pro-inflammatory M1 macrophages |
- | - Transition to anti-inflammatory, pro-repair M2 macrophages (Day 3+) |
- +-----------------------------------------------------------------------------+
- | 3. PROLIFERATION & RE-EPITHELIALISATION (Days 3 to Weeks 2-3) |
- | - Angiogenesis driven by VEGF, bFGF |
- | - Keratinocyte migration across wound bed via MMP-1, MMP-9 |
- | - Fibroblasts synthesise provisional Type III Collagen |
- | - Myofibroblasts (alpha-SMA) drive wound contraction |
- +-----------------------------------------------------------------------------+
- | 4. MATRIX REMODELLING & MATURATION (Week 3 to 1-2 Years) |
- | - Type III Collagen degraded by MMPs and replaced by Type I Collagen |
- | - Collagen bundles realign along mechanical tension lines |
- | - Tensile strength: 20% at 3 weeks, 50% at 6 weeks, max 70-80% at 1 year |
- +=============================================================================+
Haemostasis (Minutes): Local vasospasm precedes platelet adhesion to exposed subendothelial collagen via von Willebrand factor. Platelets form the primary haemostatic plug and degranulate, releasing platelet-derived growth factor ( PDGF ), transforming growth factor-beta ( TGF-beta ), and epidermal growth factor ( EGF ). The coagulation cascade cross-links fibrin and fibronectin into a provisional extracellular matrix.
Inflammation (Hours to Days): Neutrophils are recruited within minutes, peaking at 24 to 48 hours to phagocytose bacterial debris and release reactive oxygen species (ROS). Circulating monocytes infiltrate, differentiating into pro-inflammatory M1 macrophages . By day 3 to 4, clearance of apoptotic neutrophils induces phenotypic switching to M2 repair macrophages , which orchestrate tissue regeneration by secreting vascular endothelial growth factor ( VEGF ), basic fibroblast growth factor ( bFGF ), and TGF-beta.
Proliferation / Re-epithelialisation (Days 3 to 21):
Re-epithelialisation: Basal keratinocytes at wound edges and adnexal remnants downregulate desmosomes, upregulate integrins (alpha5beta1, alphavbeta6), and migrate across the provisional matrix. Keratinocyte detachment and migration requires matrix metalloproteinase-1 ( MMP-1 / interstitial collagenase ) to cleave type I collagen and MMP-9 to cleave type IV collagen.
Granulation Tissue: Fibroblasts proliferate and synthesize provisional Type III collagen . Concurrently, endothelial cells form capillary sprouts via angiogenesis in response to VEGF.
Wound Contraction: Dermal fibroblasts differentiate into myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA) , drawing wound edges together.
Remodelling / Maturation (Weeks 3 to 12–24 Months): The highly vascular granulation tissue is replaced by an avascular, collagenous scar. Matrix metalloproteinases ( MMPs ) and tissue inhibitors of metalloproteinases ( TIMPs ) balance continuous degradation of provisional Type III collagen and deposition of thick, cross-linked Type I collagen bundles organized along lines of tension ( Langer's lines ).
Critical Clinical Metric: At 3 weeks post-closure, wound tensile strength is only approximately 20% of uninjured skin. By 6 weeks, it reaches roughly 50% , and plateaus at a maximum of 70% to 80% at 1 year. Healed cutaneous scar tissue never regains 100% of the tensile strength of unwounded skin, and secondary structures (hair follicles and sweat glands) do not regenerate.